User:Mr. Ibrahem/Flibanserin

Flibanserin, sold under the brand name Addyi, is a medication used to treat women with hypoactive sexual desire disorder (HSDD). It increases the number of satisfying sexual events per month by about one half from a starting point of about two to three. The certainty of this estimate is low. It is taken by mouth.

Common side effects include dizziness, sleepiness, nausea, and tiredness. Other side effects may include low blood pressure. Use with alcohol or in those with liver problems is not recommended. There are concerns that use in pregnancy may harm the baby. It is a 5-HT1A receptor activator and 5-HT2A receptor inhibitor.

Flibanserin was approved for medical use in the United States in 2015 and Canada in 2018. As of 2021 it is not approved in the United Kingdom. In the United States it costs about 490 USD per month as of 2021.